2.385
price up icon1.27%   0.025
 
loading

Compugen Ltd Borsa (CGEN) Ultime notizie

pulisher
Jun 29, 2026

CGEN Q1 2026 Earnings: Narrowing Net Loss and Pipeline Progress Fuel OptimismGuidance Revision Trend - dars.gov.et

Jun 29, 2026
pulisher
Jun 27, 2026

Compugen Ltd (CGEN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Jun 27, 2026
pulisher
Jun 27, 2026

Compugen Ltd (CGEN) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 27, 2026
pulisher
Jun 26, 2026

Enterprise value to EBITDA forward of Compugen Ltd. – NASDAQ:CGEN - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Enterprise value to revenue forward of Compugen Ltd. – NASDAQ:CGEN - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Price to sales forward of Compugen Ltd. – NASDAQ:CGEN - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Compugen Ltd. Actuals & Estimates (NASDAQ:CGEN) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Compugen Ltd (CGEN) Institutional Confidence - TradingKey

Jun 26, 2026
pulisher
Jun 26, 2026

Compugen Ltd. Actuals & Estimates (TASE:CGEN) - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

CGEN Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

Lake Street Maintains Compugen(CGEN.US) With Buy Rating, Cuts Target Price to $5 - Moomoo

Jun 24, 2026
pulisher
Jun 18, 2026

Compugen presents ovarian cancer trial poster at ESMO meeting - Investing.com UK

Jun 18, 2026
pulisher
Jun 18, 2026

Compugen presents ovarian cancer trial poster at ESMO meeting By Investing.com - Investing.com South Africa

Jun 18, 2026
pulisher
Jun 18, 2026

Compugen spotlights COM701 ovarian trial at ESMO congress - Stock Titan

Jun 18, 2026
pulisher
Jun 18, 2026

Compugen (CGEN) Stock Faces Mixed Analyst Target Changes After Cautious Valuation Revisions - Yahoo Finance UK

Jun 18, 2026
pulisher
Jun 17, 2026

Compugen Ltd (CGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Compugen Ltd (CGEN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Compugen Ltd (CGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Compugen Ltd (CGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Compugen Ltd (CGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Compugen Ltd (CGEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Compugen Ltd (CGEN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 16, 2026

CGEN Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Stage Continues; Stock DeclinesStrong Earnings Momentum - newsline.com

Jun 16, 2026
pulisher
Jun 14, 2026

CGEN Q1 2026 Earnings: EPS Misses Estimates amid R&D FocusRevenue Beat Analysis - newsline.com

Jun 14, 2026
pulisher
Jun 14, 2026

Compugen Ltd. (CGEN) Q1 2026 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Continues Development - newsline.com

Jun 14, 2026
pulisher
Jun 11, 2026

Compugen Ltd (CGEN) to Present MAIA-Ovarian Trial Progress at Eu - GuruFocus

Jun 11, 2026
pulisher
Jun 11, 2026

Compugen to present ovarian cancer trial poster at ESMO - Investing.com UK

Jun 11, 2026
pulisher
Jun 11, 2026

Compugen to present ovarian cancer trial poster at ESMO By Investing.com - Investing.com South Africa

Jun 11, 2026
pulisher
Jun 11, 2026

AI-driven cancer firm to present ovarian trial at ESMO 2026 - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026 - Yahoo Finance

Jun 11, 2026
pulisher
Jun 09, 2026

[EFFECT] COMPUGEN LTD SEC Filing - Stock Titan

Jun 09, 2026
pulisher
Jun 08, 2026

AI cancer drug development talk with Compugen streams June 15 - Stock Titan

Jun 08, 2026
pulisher
Jun 08, 2026

Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development - TradingView

Jun 08, 2026
pulisher
Jun 07, 2026

CGEN STOCK : PRICE RECOVERY | COMPUGEN STOCK (kbWl8ONY7V) - Fathom Journal

Jun 07, 2026
pulisher
Jun 07, 2026

CGEN Q1 2026 Earnings: EPS Misses Estimates as Stock Declines on No RevenueEarnings Call Highlights - newsline.com

Jun 07, 2026
pulisher
Jun 04, 2026

H.C. Wainwright reiterates Compugen stock rating on ASCO data - Investing.com UK

Jun 04, 2026
pulisher
Jun 04, 2026

H.C. Wainwright reiterates Compugen stock rating on ASCO data By Investing.com - Investing.com Canada

Jun 04, 2026
pulisher
Jun 04, 2026

CGEN Q1 2026 Earnings: Wider-than-Expected Loss but Early-Stage Pipeline Progress Maintains MomentumCore Business Growth - dars.gov.et

Jun 04, 2026
pulisher
Jun 03, 2026

Why The Narrative Around Compugen (NasdaqCM:CGEN) Is Shifting After Analyst Resets And New Views - Yahoo Finance

Jun 03, 2026
pulisher
Jun 01, 2026

Compugen Q1 2026 Earnings Call: Complete Transcript - Benzinga

Jun 01, 2026
pulisher
May 30, 2026

Compugen Shares Slide 5.4% as Key Support Level ApproachesIV Rank - newsline.com

May 30, 2026
pulisher
May 29, 2026

Compugen (CGEN) Drops Nearly 4% as Stock Tests Key Support LevelsUndervalued Stocks - The Legal Advocate

May 29, 2026
pulisher
May 29, 2026

CGEN Q1 2026 Earnings: EPS Misses Estimates Amidst Operational ProgressAnalyst Coverage Count - dars.gov.et

May 29, 2026
pulisher
May 28, 2026

Compugen surges after revenue tops forecasts despite quarterly loss miss (CGEN) - MSN

May 28, 2026
pulisher
May 27, 2026

Earnings Preview: Compugen to Report Financial Results Pre-market on May 18 - Moomoo

May 27, 2026
pulisher
May 26, 2026

CGENCompugen Ltd Stock Price and Quote - Finviz

May 26, 2026
pulisher
May 26, 2026

Compugen Ltd (CGEN) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus

May 26, 2026
$113.07
price up icon 1.38%
$35.27
price up icon 0.23%
$57.70
price up icon 1.38%
$78.94
price down icon 3.59%
ONC ONC
$305.62
price down icon 1.15%
$190.47
price up icon 0.31%
Capitalizzazione:     |  Volume (24 ore):